AbbVie: all 2,241 studies

Page 4 of 23. Open to participants first (134), then studies with results posted, then the rest; newest registration first within each.

• Submental Study (Sequential Treatment Approach)CompletedNCT03510598Phase 4Results posted
• Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisCompletedNCT03478787Phase 3Results posted
• Eluxadoline Bile Acid Malabsorption (BAM) StudyCompletedNCT03441581Phase 4Results posted
• A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using CannulaCompletedNCT03438266Not applicableResults posted
• Safety and Effectiveness of JUVÉDERM® VOLUMA® With Lidocaine for Improvement of Volume and Aesthetic Appearance of the Nose in Chinese AdultsCompletedNCT03430986Not applicableResults posted
• Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in AbdominoplastyTerminatedNCT03429556Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02TerminatedNCT03426345Phase 3Results posted
• Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline ContourCompletedNCT03425253Phase 4Results posted
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03TerminatedNCT03420781Phase 3Results posted
• UNITE Study: Understanding New Interventions With GBM ThErapyTerminatedNCT03419403Phase 3Results posted
• A Safety and Effectiveness of VOLBELLA XC Hyaluronic Acid (HA) Injectable Gel to Correct Infraorbital HollowingCompletedNCT03418545Phase 3Results posted
• A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination TherapyCompletedNCT03406156Phase 3Results posted
• A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03398148Phase 2/3Results posted
• An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)TerminatedNCT03391765Phase 2Results posted
• Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCNActive, not recruitingNCT03386513Phase 1/2Results posted
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04TerminatedNCT03383146Phase 3Results posted
• A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and BevacizumabTerminatedNCT03368859Phase 2Results posted
• Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure GlaucomaCompletedNCT03362931Phase 3Results posted
• COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal GelCompletedNCT03362879Results posted
• A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive DisorderTerminatedNCT03352453Phase 2Results posted
• Cryolipolysis for Jawline ContouringCompletedNCT03352141Not applicableResults posted
• A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic TherapiesCompletedNCT03345849Phase 3Results posted
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic TherapyCompletedNCT03345836Phase 3Results posted
• A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe PainTerminatedNCT03343067Phase 3Results posted
• Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus ControlCompletedNCT03325673Not applicableResults posted
• BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary IncontinenceCompletedNCT03320850Phase 2Results posted
• Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe PhotodamageCompletedNCT03302559Not applicableResults posted
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01TerminatedNCT03285308Phase 3Results posted
• Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ UseTerminatedNCT03274999Not applicableResults posted
• Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT03271489Phase 3Results posted
• A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)TerminatedNCT03258814Results posted
• A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic TherapyCompletedNCT03255382Phase 3Results posted
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
• Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT03233438Phase 4Results posted
• Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland DiseaseCompletedNCT03226769Not applicableResults posted
• A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With MyelofibrosisCompletedNCT03222609Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 InfectionCompletedNCT03219216Phase 3Results posted
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated PainCompletedNCT03213457Phase 3Results posted
• Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1CompletedNCT03212521Phase 3Results posted
• Optive Brand For Day And Night Dry Eye ManagementCompletedNCT03208673Not applicableResults posted
• A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing SpondylitisCompletedNCT03178487Phase 2Results posted
• Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple HollowingTerminatedNCT03166618Not applicableResults posted
• Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective EndocarditisTerminatedNCT03148756Phase 2Results posted
• Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)CompletedNCT03112174Phase 3Results posted
• A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseCompletedNCT03105128Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic TreatmentCompletedNCT03104413Phase 3Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)CompletedNCT03104400Phase 3Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugCompletedNCT03104374Phase 3Results posted
• Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With OsteomyelitisTerminatedNCT03091439Phase 2Results posted
• A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated CirrhosisCompletedNCT03089944Phase 3Results posted
• A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDsCompletedNCT03086343Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal ImpairmentCompletedNCT03069365Phase 3Results posted
• A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive ChemotherapyCompletedNCT03069352Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03067129Phase 2/3Results posted
• Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)CompletedNCT03061812Phase 3Results posted
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic SteatohepatitisTerminatedNCT03059446Phase 2Results posted
• Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian FederationCompletedNCT03053180Results posted
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary IncontinenceCompletedNCT03052764Phase 4Results posted
• A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )CompletedNCT03047395Phase 3Results posted
• A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)TerminatedNCT03033511Phase 3Results posted
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)TerminatedNCT03028740Phase 3Results posted
• A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung CancerTerminatedNCT03026166Phase 1/2Results posted
• A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCompletedNCT03022045Phase 3Results posted
• Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)CompletedNCT03002818Results posted
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT03002077Phase 3Results posted
• BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03000075Phase 2Results posted
• A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction TherapyActive, not recruitingNCT02993523Phase 3Results posted
• A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)CompletedNCT02986373Phase 2Results posted
• A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)TerminatedNCT02985879Phase 2Results posted
• A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin DepressionsCompletedNCT02980783Phase 4Results posted
• A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).CompletedNCT02980731Phase 3Results posted
• Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial MelasmaCompletedNCT02977507Not applicableResults posted
• A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of BelarusCompletedNCT02968173Phase 3Results posted
• A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 InfectionCompletedNCT02966795Phase 3Results posted
• Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry EyeTerminatedNCT02965846Phase 3Results posted
• Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT02961764Phase 4Results posted
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide UseCompletedNCT02959983Phase 4Results posted
• Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)CompletedNCT02959944Phase 3Results posted
• A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)CompletedNCT02955212Phase 3Results posted
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive DisorderCompletedNCT02951988Phase 3Results posted
• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular LymphomaCompletedNCT02947347Phase 3Results posted
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)CompletedNCT02943577Phase 3Results posted
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)CompletedNCT02943564Phase 3Results posted
• DualSculpting the Abdomen Using CoolSculptingCompletedNCT02941146Not applicableResults posted
• Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical StudyCompletedNCT02939989Phase 3Results posted
• CoolSculpting Treatment in the Upper ArmsCompletedNCT02939105Not applicableResults posted
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)CompletedNCT02932943Phase 3Results posted
• An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT02925494Phase 3Results posted
• A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic DermatitisCompletedNCT02925117Phase 2Results posted
• Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal NeurostimulationCompletedNCT02910713Not applicableResults posted
• Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)CompletedNCT02910583Phase 2Results posted
• Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis SuppurativaCompletedNCT02904902Phase 3Results posted
• Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple MyelomaCompletedNCT02902965Phase 2Results posted
• A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine TreatmentTerminatedNCT02897115Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseCompletedNCT02880956Phase 2Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of MigraineCompletedNCT02873221Phase 3Results posted
• Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of MigraineCompletedNCT02867709Phase 3Results posted
• Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in ColombiaCompletedNCT02851069Results posted
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine PreventionCompletedNCT02848326Phase 2/3Results posted

← AbbVie overview and focus areas